Revolution Medicines, Inc (RVMD) insider trading
Every open-market stock purchase and sale by Revolution Medicines, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Mark A Goldsmith (Insider) and 8 others sold $78M in the last 90 days.
- Last insider buy: Thilo Schroeder (Insider), $35M, 23 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $154M (54 sales). Last close $194.28 on Oct 21, 2026.
Recent RVMD insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 29, 2026 | Alan B. Sandler (C-suite exec) | Sold | $442K |
| Sep 29, 2026 | Alan B. Sandler (C-suite exec) | Sold | $325K |
| Sep 29, 2026 | Alan B. Sandler (C-suite exec) | Sold | $244K |
| Sep 29, 2026 | Alan B. Sandler (C-suite exec) | Sold | $203K |
| Sep 29, 2026 | Alan B. Sandler (C-suite exec) | Sold | $61.6K |
| Sep 29, 2026 | Alan B. Sandler (C-suite exec) | Bought (not open market) | — |
| Sep 25, 2026 | Anthony Mancini (Insider) | Sold | $626K |
| Sep 25, 2026 | Jeff Cislini (VP) | Sold | $159K |
| Sep 25, 2026 | Anthony Mancini (Insider) | Bought (not open market) | — |
| Sep 24, 2026 | Anthony Mancini (Insider) | Sold | $117K |
| Sep 22, 2026 | Elizabeth M Anderson (Insider) | Sold | $960K |
| Sep 22, 2026 | Elizabeth M Anderson (Insider) | Sold | $512K |
| Sep 22, 2026 | Elizabeth M Anderson (Insider) | Sold | $292K |
| Sep 22, 2026 | Elizabeth M Anderson (Insider) | Sold | $175K |
| Sep 22, 2026 | Elizabeth M Anderson (Insider) | Sold | $19.5K |
| Sep 22, 2026 | Elizabeth M Anderson (Insider) | Bought (not open market) | — |
| Sep 18, 2026 | Anthony Mancini (Insider) | Sold | $347K |
| Sep 16, 2026 | Mark A Goldsmith (Insider) | Sold | $2.7M |
| Sep 16, 2026 | Stephen Michael Kelsey (Insider) | Sold | $1.1M |
| Sep 16, 2026 | Margaret A Horn (COO) | Sold | $975K |
| Sep 16, 2026 | Jack Anders (CFO) | Sold | $796K |
| Sep 16, 2026 | Jeff Cislini (VP) | Sold | $660K |
| Sep 16, 2026 | Anthony Mancini (Insider) | Sold | $348K |
| Sep 16, 2026 | Alan B. Sandler (C-suite exec) | Sold | $67K |
| Sep 16, 2026 | Mark A Goldsmith (Insider) | Sold | $41.5K |
Who's trading RVMD
- Alan B. Sandler, C-suite exec: sold $1.3M (7 sales), last Sep 29, 2026
- Jeff Cislini, General Counsel: sold $14.6M (15 sales), last Sep 25, 2026
- Anthony Mancini, Insider: sold $9.8M (22 sales), last Sep 25, 2026
- Elizabeth M Anderson, Insider: sold $2M (5 sales), last Sep 22, 2026
- Stephen Michael Kelsey, Insider: sold $21.3M (13 sales), last Sep 16, 2026
- Jack Anders, CFO: sold $7.1M (12 sales), last Sep 16, 2026
- Mark A Goldsmith, Insider: sold $55.7M (41 sales), last Sep 16, 2026
- Margaret A Horn, COO: sold $25.3M (16 sales), last Sep 16, 2026
- Lorence H. Kim, Insider: sold $15M (14 sales), last Sep 8, 2026
- Sushil Patel, Insider: sold $1M (9 sales), last Jun 29, 2026
- Alexis Borisy, Insider: other filings, last Jun 18, 2026
- Flavia Borellini, Insider: other filings, last Jun 18, 2026
- Sandra Horning, Insider: other filings, last Jun 18, 2026
- Frank Clyburn, Insider: other filings, last Jun 18, 2026
- Xiaolin Wang, Insider: sold $200K (1 sale), last Mar 17, 2026
Get free alerts when an insider at Revolution Medicines, Inc files a new trade →